533
Views
23
CrossRef citations to date
0
Altmetric
Letters to the Journal

CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype

, , , &

References

  • Gilmour DF. Familial exudative vitreoretinopathy and related retinopathies. Eye 2015;29:1–14.
  • Robitaille J, MacDonald ML, Kaykas A, et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nature Genet 2002;32:326–330.
  • Toomes C, Bottomley HM, Jackson RM, et al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Human Genet 2004;74:721–730.
  • Chen ZY, Battinelli EM, Fielder A, et al. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nature Genet 1993;5:180–183.
  • Nikopoulos K, Gilissen C, Hoischen A, et al. Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. Am J Human Genet 2010;86:240–247.
  • Poulter JA, Ali M, Gilmour DF, et al. Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. Am J Human Genet 2010;86:248–253.
  • Collin RW, Nikopoulos K, Dona M, et al. ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature. Proc Natl Acad Sci U S A 2013;110:9856–9861.
  • Warden SM, Andreoli CM, Mukai S. The Wnt signaling pathway in familial exudative vitreoretinopathy and Norrie disease. Sem Ophthalmol 2007;22:211–217.
  • Niehrs C, Acebron SP. Mitotic and mitogenic Wnt signalling. EMBO J 2012;31:2705–2713.
  • MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009;17:9–26.
  • Niehrs C. The complex world of WNT receptor signalling. Nature Rev Mol Cell Biol 2012;13:767–779.
  • Rubinfeld B, Souza B, Albert I, et al. Association of the APC gene product with beta-catenin. Science 1993;262(5140):1731–1734.
  • Fu Y, Zheng S, An N, et al. beta-catenin as a potential key target for tumor suppression. Int J Cancer 2011;129:1541–1551.
  • Dubruc E, Putoux A, Labalme A, et al. A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency. Am J Med Genet Part A 2014;164A:1571–1575.
  • Kuechler A, Willemsen MH, Albrecht B, et al. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum. Human Genet 2015;134:97–109.
  • Tucci V, Kleefstra T, Hardy A, et al. Dominant beta-catenin mutations cause intellectual disability with recognizable syndromic features. J Clin Invest 2014;124:1468–1482.
  • Kashani AH, Brown KT, Chang E, et al. Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy. Ophthalmology 2014;121:2220–2227.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.